- June 30, 2020
-- COVID-19 pandemic has caused a tremendous shift in medical focus from almost every disorder to COVID-19 treatment. It has been observed that each step in cancer management pathway has been disrupted by COVID-19 virus that are diagnosis, screening, treatment, research and development. This pandemic will most certainly continue to have an impact on cancer patients and their treatment for the foreseeable future.
Through this whitepaper, we have enlightened about the effect of COVID-19 on oncology diagnosis, screening, patient outcomes, treatment modalities, clinical trials, availability of drugs, clinical advancements and what pharmaceutical companies are doing to fight with this situation.
The coronavirus pandemic of 2019–2020 is an infectious disease caused by extreme acute respiratory coronavirus syndrome 2 (SARS‐CoV‐
2). The virus primarily spread among people when they closely meet each other. Due to the decreased immune-compromised state, cancer patients are known to be at greater risk among community-acquired respiratory viruses such as influenza, SARS CoV-2 virus, etc. The treatment regimens of cancer such as chemotherapy, immunotherapy, and radiation therapy harm patient's immunity making them more prone to the risk of getting infected with COVID-19 virus. COVID-19 pandemic is impacting at every stage of cancer care i.e. screening, diagnosis, treatment, research, and development. Through this whitepaper, we have enlighted about the effect COVID-19 virus in cancer patients.https://www.iebrain.com/wp-content/uploads/2020/06/impact...
207208 Welldone TechPark, Sohna Road
Sector 48, Gurugram,Haryana, India
+91 124 429 email@example.com